Jo Raskin unpaid staff

Publications Jo Raskin

INSIGHT 2 : a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance

Source
Future oncology - ISSN 1479-6694- () p.
Author(s)
    Egbert F. Smit, Christophe Dooms, Jo Raskin, Ernest Nadal, Lye M. Tho, Xiuning Le, Julien Mazieres, How S. Hin, Masahire Morise, Viola W. Zhu, Daniel Tan, Kristina H. Holmberg, Barbara Ellers-Lenz, Svenja Adrian, Sabine Brutlach, Karl M. Schumacher, Niki Karachaliou, Yi-Long Wu

Optimizing COPD care in Belgium : a multidisciplinary expert consensus on cardiopulmonary risk management

Source
International journal of chronic obstructive pulmonary disease - ISSN 1178-2005-21 (2026) p. 1-20
Author(s)
    Naomi Michotte, Fabian Demeure, Julien Guiot, Sander Trenson, Michiel J.E.G.W. Vanfleteren, Lies Lahousse, Jo Raskin, Didier Cataldo, Therese Lapperre, Eric Marchand, Mathias Leys, Wim Janssens, Marie Bruyneel, Lowie E.G.W. Vanfleteren, Eef Vanderhelst, Pieter Goeminne, Stefan Teughels, Muriel Lins, Ines Van Rossem, Rudi Peche

Neoadjuvant systemic therapy for pleural mesothelioma patients : a systematic review

Source
Translational lung cancer research - ISSN 2218-6751-14:10 (2025) p. 1-12
Author(s)
    Illaa Smesseim, Jo Raskin, Jacobus A. Burgers